5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11CONFIRMED▲ Above MA200+0.6% from MA200, price crossed above
▲ Above MA150+0.4% from MA150, price crossed above
Jul 10CONFIRMED▲ Above MA150+0.4% from MA150, price crossed above
▲ Above MA200+0.6% from MA200, price crossed above
About Oaktree Acquisition Corp. III Life Sciences
III Life Sciences does not have significant operations. At a $263.0M market cap, Oaktree Acquisition Corp. III Life Sciences ranks as a micro-cap company within financial services. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Premium feature
News & analytics is part of Premium.
Every headline runs through our finance-grade sentiment engine, so you see the mood of the market on each ticker before you read a single article. Plus the full analyst consensus and target-price upside, refreshed daily.
Per-headline sentiment, scored by a finance-tuned model
See exactly where the price sits versus its 150-day moving average, the live RSI reading, MACD momentum, and volume context, for any ticker, every day.
With $1.3M in cash and $12K in debt, OACC maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Oaktree Acquisition Corp. III Life Sciences's trajectory.